Danushka K. Wijesundara - Search Results

Year	Number of Results
2010	2
2011	1
2012	2
2013	4
2014	5
2017	3
2018	1
2019	4
2020	5
2021	4
2022	0

1

Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines.

Shrestha AC, Wijesundara DK, Masavuli MG, Mekonnen ZA, Gowans EJ, Grubor-Bauk B. Shrestha AC, et al. Among authors: wijesundara dk. Vaccines (Basel). 2019 Apr 30;7(2):38. doi: 10.3390/vaccines7020038. Vaccines (Basel). 2019. PMID: 31052178 Free PMC article. Review.

2

IL-4 and IL-13 receptors: Roles in immunity and powerful vaccine adjuvants.

Ranasinghe C, Trivedi S, Wijesundara DK, Jackson RJ. Ranasinghe C, et al. Among authors: wijesundara dk. Cytokine Growth Factor Rev. 2014 Aug;25(4):437-42. doi: 10.1016/j.cytogfr.2014.07.010. Epub 2014 Jul 23. Cytokine Growth Factor Rev. 2014. PMID: 25159217 Review.

3

Emerging Targets for Developing T Cell-Mediated Vaccines for Human Immunodeficiency Virus (HIV)-1.

Wijesundara DK, Ranasinghe C, Grubor-Bauk B, Gowans EJ. Wijesundara DK, et al. Front Microbiol. 2017 Oct 25;8:2091. doi: 10.3389/fmicb.2017.02091. eCollection 2017. Front Microbiol. 2017. PMID: 29118747 Free PMC article. Review.

4

Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C.

Masavuli MG, Wijesundara DK, Torresi J, Gowans EJ, Grubor-Bauk B. Masavuli MG, et al. Among authors: wijesundara dk. Front Microbiol. 2017 Dec 5;8:2413. doi: 10.3389/fmicb.2017.02413. eCollection 2017. Front Microbiol. 2017. PMID: 29259601 Free PMC article. Review.

5

Toward DNA-Based T-Cell Mediated Vaccines to Target HIV-1 and Hepatitis C Virus: Approaches to Elicit Localized Immunity for Protection.

Mekonnen ZA, Grubor-Bauk B, Masavuli MG, Shrestha AC, Ranasinghe C, Bull RA, Lloyd AR, Gowans EJ, Wijesundara DK. Mekonnen ZA, et al. Among authors: wijesundara dk. Front Cell Infect Microbiol. 2019 Apr 3;9:91. doi: 10.3389/fcimb.2019.00091. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31001491 Free PMC article. Review.

6

Fear of Influenza Resurgence amid COVID-19 Pandemic: Need for Effective Flu Vaccine Still Exists.

Wijesundara DK, Williams C, Sun W, Furuya AM, Furuya Y. Wijesundara DK, et al. Vaccines (Basel). 2021 Oct 18;9(10):1198. doi: 10.3390/vaccines9101198. Vaccines (Basel). 2021. PMID: 34696304 Free PMC article.

7

Use and misuse of statistical significance in survival analyses.

Furuya Y, Wijesundara DK, Neeman T, Metzger DW. Furuya Y, et al. Among authors: wijesundara dk. mBio. 2014 Mar 4;5(2):e00904-14. doi: 10.1128/mBio.00904-14. mBio. 2014. PMID: 24595371 Free PMC article.

8

Immunological Memory in Imiquimod-Induced Murine Model of Psoriasiform Dermatitis.

Fenix K, Wijesundara DK, Cowin AJ, Grubor-Bauk B, Kopecki Z. Fenix K, et al. Among authors: wijesundara dk. Int J Mol Sci. 2020 Sep 30;21(19):7228. doi: 10.3390/ijms21197228. Int J Mol Sci. 2020. PMID: 33007963 Free PMC article.

9

Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective Immunity.

Roy S, Williams CM, Pardo J, Wijesundara DK, Furuya Y. Roy S, et al. Among authors: wijesundara dk. Vaccines (Basel). 2020 Aug 20;8(3):459. doi: 10.3390/vaccines8030459. Vaccines (Basel). 2020. PMID: 32825218 Free PMC article.

10

Rapid Response Subunit Vaccine Design in the Absence of Structural Information.

Wijesundara DK, Avumegah MS, Lackenby J, Modhiran N, Isaacs A, Young PR, Watterson D, Chappell KJ. Wijesundara DK, et al. Front Immunol. 2020 Nov 4;11:592370. doi: 10.3389/fimmu.2020.592370. eCollection 2020. Front Immunol. 2020. PMID: 33250897 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results